ČESKÁ UROLOGIE / CZECH UROLOGY – 2 / 2020

145 KAZUISTIKY Ces Urol 2020; 24(2): 141–145 7. Hora M, Stránský P, Eret V, et al. Integrace chirurgické a biologické léčby u pokročilého renálního kar‑ cinomu. Ces Urol 2011; 15(3): 149–157. 8. Gaujoux S, Cortes A, Couvelard A, et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery 2010; 148: 15–23. 9. Matsusue S, Takeda H, Nakamura Y, Nishimura S, Koizumi S. A prospective analysis of the factors influencing pancreaticojejunostomy performed using a single method, in 100 consecutive pancreatico‑ duodenectomies. Surg Today 1998; 28: 719–726. 10. Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo‑controlled trial. Ann Surg 2000; 232: 419–429. 11. Kleeff J, Diener MK, Z’graggen K, et al. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg 2007; 245: 573–582. 12. Ferrone CR, Warshaw AL, Rattner DW, et al. Pancreatic fistula rates after 462 distal pancreatectomies: staplers do not decrease fistula rates. J Gastrointest Surg 2008; 12: 1691–1697. 13. Nathan H, Cameron JL, Goodwin CR, et al. Risk factors for pancreatic leak after distal pancreatectomy. Ann Surg 2009; 250: 277–281. 14. Reeh M, Nentwich MF, Bogoevski D, et al. High surgical morbidity following distal pancreatectomy: still an unsolved problem. World J Surg 2011; 35: 1110–1117. 15. Kazanjian KK, Hines OJ, Eibl G, et al. Management of pancreatic fistulas after pancreaticoduodenec‑ tomy: results in 437 consecutive patients. Arch Surg 2005; 140(9): 849–855. 16. Grobmyer SR, Hunt DL, Forsmark CE, et al. Pancreatic stent placement is associated with resolution of refractory grade C pancreatic fistula after left‑sidedpancreatectomy. Am Surg 2009; 75: 654–657.